The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Behl Charan since 2008.
The trader's CIK number is 1350693.
At the time of the last reporting, Behl Charan was the Other of Elite Pharmaceuticals Inc /de/. (stock ticker symbol ELI).
Also see all insider trading activities at Elite Pharmaceuticals Inc /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | ELI | 193,000 | $127,385 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-09-19 | ELI | Buy | 10,000 | .09 | 900 |
| 2008-07-23 | ELI | Buy | 10,000 | .33 | 3,300 |
| 2008-07-21 | ELI | Buy | 10,000 | .36 | 3,650 |
| 2008-07-23 | ELI | Buy | 10,000 | .34 | 3,400 |
| 2008-07-18 | ELI | Buy | 10,000 | .37 | 3,700 |
| 2008-07-17 | ELI | Buy | 15,000 | .35 | 5,250 |
| 2008-07-15 | ELI | Buy | 5,000 | .34 | 1,700 |
| 2008-07-09 | ELI | Buy | 15,000 | .40 | 5,940 |
| 2008-04-02 | ELI | Buy | 15,000 | .80 | 12,000 |
| 2008-03-28 | ELI | Buy | 5,000 | .90 | 4,500 |
| 2008-03-26 | ELI | Buy | 5,000 | .96 | 4,795 |
| 2008-02-07 | ELI | Buy | 10,000 | .90 | 9,000 |
| 2008-02-08 | ELI | Buy | 5,000 | 1.04 | 5,225 |
| 2008-02-05 | ELI | Buy | 25,000 | .77 | 19,125 |
| 2008-01-29 | ELI | Buy | 10,000 | 1.00 | 10,000 |
| 2008-01-30 | ELI | Buy | 15,000 | .94 | 14,100 |
| 2008-01-28 | ELI | Buy | 4,000 | 1.15 | 4,600 |
| 2008-01-25 | ELI | Buy | 5,000 | 1.16 | 5,800 |
| 2008-01-28 | ELI | Buy | 4,000 | 1.15 | 4,600 |
| 2008-01-25 | ELI | Buy | 5,000 | 1.16 | 5,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Behl Charan (Other of Elite Pharmaceuticals Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.